A final oral solid dose drug product can be achieved in many ways and there is no “one fits all”. We look at each drug substance including its specific characteristics, final application, target patient groups and markets to develop the best solution for our partners.
We love the challenges and hurdles to overcome and to improve the way the drug finally behaves. The combined knowledge of our partners and us leads to the most succesful results.
Link to: Controlled Release
Controlled Release
The control of the drug release from immediate, pulsatile, delayed on prolonged is a key competence of our formulation and process development solutions. The application of functional coatings on multiparticulates such a micropellets, pellets and mini tablets is just one of various solutions offered.
Link to: Solubility Enhancement
Solubility Enhancement
The drug substances (APIs) offer more challenges in the field of solubility and bioavailability. Over 80% of new APIs behave badly when it comes to solubility being classified as BCS Class II compounds. Innovative solutions for optimum donwstream processes and final drug products are our answer.
Link to: Geriatric&Pediatric
Geriatric & Pediatric
Size matters in these special patient groups in different ways. The paediatric populations vary strongly within the different age groups. The common challenges in paediatrics and geriatrics are taste, palatability and swallowability. We adress all of them with our solutions for multiparticulates and ODTs (Orally disintegrating tablets).
Link to: Taste Masking
Taste Masking
Taste issues can be handled in many ways. When adding of flavors is not sufficient it becomes interesting for us how to block the taste. Encapsulation and functional coatings to control the drug release are possible solutions.
Link to: Animal Health
Animal Health
Animal health products, especially for companion animals have specific challenges when it comes to taste and administration. We offer a longlasting experience and various solutions to adress those challenges.
Link to: High potent API
High potent API
The majority of new chemical entities (NCE) coming into the pharmaceutical development are considered high or highly potent and need specific handling measurements especially to protect the staff working with them.
Link to: Sensitive API
Sensitive API
Glatt Pharmaceutical Services ensures precise, secure management of sensitive APIs, addressing potency, stability, and compliance challenges. We deliver tailored solutions to transform complex compounds into effective therapies.